UNSPSC 51151647: Leiopyrrole

This classification denotes an anticholinergic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S1URO6678T. European Medicines Agency schedules Leiopyrrole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08426MIG. Leiopyrrole generally arises in the molecular formula C23H28N2O.

UNSPSC 51151647 Leiopyrrole is a Commodity code that in recent state and local procurement shows no relevant activity. The single opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems posted June 30, 2026—addresses pharmaceutical products and medical supplies entirely outside the scope of leiopyrrole (a heterocyclic organic compound used in specialty chemical synthesis). A second record, the Texas Health and Human Services Commission RFI HHS0017013 on direct-to-manufacturer prescription programs from April 3, 2026, addresses pharmacy benefit management and contracting architecture, not chemical commodities. The code appears to have been applied to these health-sector procurement activities in error, suggesting significant tagging misalignment between the UNSPSC taxonomy and the actual sourcing activities being labeled.

No state or local government opportunities directly soliciting leiopyrrole or related specialty chemicals under this Commodity code are present in the recent record. Business development teams evaluating this code should verify that opportunities claiming this UNSPSC designation are accurately classified before allocating pursuit resources, as current activity reflects procurement misalignment rather than substantive demand in the leiopyrrole commodity space.